E Fund Management Co., Ltd. Ardelyx, Inc. Transaction History
E Fund Management Co., Ltd.
- $2.06 Billion
- Q2 2025
A detailed history of E Fund Management Co., Ltd. transactions in Ardelyx, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 40,023 shares of ARDX stock, worth $234,935. This represents 0.01% of its overall portfolio holdings.
Number of Shares
40,023
Previous 36,768
8.85%
Holding current value
$234,935
Previous $180,000
13.33%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding ARDX
# of Institutions
244Shares Held
161MCall Options Held
697KPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA18.4MShares$108 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$103 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X013.8MShares$81.1 Million0.04% of portfolio
-
Macquarie Group LTD Australia, C310.5MShares$61.4 Million0.07% of portfolio
-
State Street Corp Boston, MA9.72MShares$57 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $908M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...